articleTop 10% cited
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors
Neuropharmacology · 1998 · Vol. 37(1) · pp. 1–12
Anne KingstonPaul L. Ornstein(Eli Lilly (United States))Rebecca A. Wright(Eli Lilly (United States))Bryan G. Johnson(Eli Lilly (United States))Nancy G. Mayne(Eli Lilly (United States))J. Paul Burnett(Eli Lilly (United States))Rama M. Belagaje(Eli Lilly (United States))Song Wu(Eli Lilly (United States))Darryle D. Schoepp✉(Eli Lilly (United States))
Neuroscience and Neuropharmacology ResearchIon channel regulation and functionMolecular Sensors and Ion DetectionMetabotropic glutamate receptorMetabotropic receptorMetabotropic glutamate receptor 1Ionotropic effectMetabotropic glutamate receptor 5PharmacologyMetabotropic glutamate receptor 2ReceptorGlutamate receptorAntagonist
MeSH terms
Cyclic AMPAmino AcidsAnimalsCell LineColforsinHumansXanthenesProsencephalonReceptors, Metabotropic GlutamateExcitatory Amino Acid AntagonistsRats
Citations
364
FWCI
4.77
field-weighted impact
References
35
Percentile
96%
vs. same field & year
Citations per year
Cited by
Pharmacological agents acting at subtypes of metabotropic glutamate receptors
Neuropharmacology · 1999 · 1,055 citations
Ionotropic and metabotropic glutamate receptor structure and pharmacology
Psychopharmacology · 2005 · 777 citations
References
The metabotropic glutamate receptors: Structure and functions
Neuropharmacology · 1995 · 2,257 citations
Metabotropic glutamate receptors in brain function and pathology
Trends in Pharmacological Sciences · 1993 · 794 citations
Cloned Glutamate Receptors
Annual Review of Neuroscience · 1994 · 3,973 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.